NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Simple Peptide? Mail in a sample (US only) and let us test it.

Test my supply
+4 more ↓
60%
Finnrick rating
#434 of 500 ranked vendors
32 of 56 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Simple Peptide's purity-focus record is strongest on Tirzepatide and GHK-Cu, with Retatrutide helped by a recent pass streak but still marked by batch-level purity volatility. Weaker signals cluster in CJC-1295, Melanotan II, and BPC-157, and the evidence is recent and broad but uneven, with several results concentrated in same-batch runs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Simple Peptide

Corporate filings, web infrastructure and payment rails map Simple Peptide into a Melex-controlled network spanning RUO retail, wholesale, telehealth, API and exosome channels. A brand-identical .is storefront, Ascellos positioning and lab-relationship caveats complicate the clean COA story.

38 pages9 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.55
85%
6
2
Tirzepatide
$7.47
82%
9
3
Retatrutide
$8.00
69%
18
4
Ipamorelin
$7.60
67%
3
5
Semaglutide
$7.47
64%
4
6
Melanotan II
$3.30
54%
3
7
BPC-157
$5.10
48%
4
8
Tesamorelin
$7.13
48%
4
9
Sermorelin
$9.80
45%
2
10
CJC-1295
$10.40
26%
3
12
TB-500
$6.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%30 Apr 2025: 48%30 Apr 2025: 48%30 Apr 2025: 47%2 May 2025: 47%2 May 2025: 46%6 May 2025: 46%6 May 2025: 46%7 May 2025: 47%4 Aug 2025: 53%3 Oct 2025: 53%18 Feb 2026: 54%20 Feb 2026: 52%20 Feb 2026: 52%26 Feb 2026: 53%6 Mar 2026: 56%6 Mar 2026: 56%18 Mar 2026: 54%28 Apr 2026: 55%5 May 2026: 55%9 Jul 2026: 55%9 Jul 2026: 55%13 Jul 2026: 54%14 Jul 2026: 55%13 Aug 2026: 55%4 Sep 2026: 54%4 Sep 2026: 54%4 Sep 2026: 54%5 Sep 2026: 55%5 Sep 2026: 57%5 Sep 2026: 58%24 Sep 2026: 58%5 Oct 2026: 57%5 Oct 2026: 57%8 Oct 2026: 57%8 Oct 2026: 57%20 Oct 2026: 57%23 Oct 2026: 57%2 Nov 2026: 57%2 Nov 2026: 57%5 Nov 2026: 57%17 Nov 2026: current 60%48%54%60%Apr 25Nov 26
Peptide testing

Ordered peptides from Simple Peptide? Mail in a sample (US only) and let us test it.

Test my supply
Simple Peptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
5 Nov 2026
Pass
Tirzepatide
lab nameView COA
2 Nov 2026
Fail
Retatrutide
lab nameView COA
2 Nov 2026
Fail
Tesamorelin
lab nameView COA
23 Oct 2026
Pass
GHK-Cu
lab nameView COA
20 Oct 2026
Pass
Retatrutide
lab nameView COA
8 Oct 2026
Pass
Retatrutide
lab nameView COA
8 Oct 2026
Pass
Tirzepatide
lab nameView COA
5 Oct 2026
Fail
Retatrutide
lab nameView COA
5 Oct 2026
Fail
Tesamorelin
lab nameView COA
24 Sep 2026
Pass
GHK-Cu
lab nameView COA
1-10 of 56

About Simple Peptide test results from Finnrick

Simple Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 56 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Simple Peptide peptides in this dataset are BPC-157 (4 tests), CJC-1295 (3 tests) and GHK-Cu (6 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 56 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Simple Peptide? Mail in a sample (US only) and let us test it.

Test my supply